Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M–positive non–small cell lung cancer: West Japan Oncology Group 8815L/LPS study

Cancer ◽  
2020 ◽  
Vol 126 (9) ◽  
pp. 1940-1948 ◽  
Author(s):  
Takayuki Takahama ◽  
Koichi Azuma ◽  
Mototsugu Shimokawa ◽  
Masayuki Takeda ◽  
Hidenobu Ishii ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase 2 ◽  
Oncology Group ◽  
Small Cell Lung ◽  
T790m Mutation ◽  
Plasma Screening ◽  
Phase 2 Study

Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer

Lung Cancer ◽  
2012 ◽  
Vol 76 (1) ◽  
pp. 78-83 ◽  
Author(s):  
Benjamin Besse ◽  
David Planchard ◽  
Anne-Sophie Veillard ◽  
Laurent Taillade ◽  
David Khayat ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Phase 2 Study
Sign in / Sign up

Export Citation Format

Share Document